Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!"

Fertil Steril. 2014 Aug;102(2):339-41. doi: 10.1016/j.fertnstert.2014.04.047. Epub 2014 Jun 4.

Authors

Peter Humaidan¹, Nikolaos P Polyzos²

Affiliations

¹ Faculty of Health, Aarhus University, and The Fertility Clinic, Skive Regional Hospital, Skive, Denmark.
² Center for Reproductive Medicine, Universiteit Ziekenhuis Brussel, VUB, Brussels, Belgium.

PMID: 24907915
DOI: 10.1016/j.fertnstert.2014.04.047

No abstract available

MeSH terms

Chorionic Gonadotropin / adverse effects
Chorionic Gonadotropin / therapeutic use*
Embryo Transfer
Female
Fertility / drug effects*
Fertility Agents, Female / adverse effects
Fertility Agents, Female / therapeutic use*
Fertilization in Vitro
Gonadotropin-Releasing Hormone / agonists*
Gonadotropin-Releasing Hormone / metabolism
Humans
Infertility / drug therapy*
Infertility / physiopathology
Oocyte Retrieval
Ovary / drug effects*
Ovary / metabolism
Ovary / physiopathology
Ovulation / drug effects*
Ovulation Induction / adverse effects
Ovulation Induction / methods*
Pregnancy
Treatment Outcome

Substances

Chorionic Gonadotropin
Fertility Agents, Female
Gonadotropin-Releasing Hormone